Ericsson is shaping the future of mobile broadband Internet communications through its continuous technology leadership, helping to create the most powerful communication companies.

Ericsson Business related to below areas:

Sweden based Sandvik company is a high-tech and global engineering Group with about 43,000 employees. Manufactures Metal-cutting tools and tooling systems, Mining and rock excavation equipment and tools, Stainless steels, special alloys and titanium, Additive manufacturing, Furnace products and heating systems.

Sandvik is world-leading positions in the following areas:

Telia Company is Sweden based multi-national Telecom company providing Mobile Network Services and Internet Network Services.

Oil and Gas Exploration and Production company with headquarters in Stockholm, Sweden.

Alfa Laval Sweden based multi-national technology company and  today a world leader within the key technology areas of heat transfer, separation and fluid handling. Alfa Laval’s worldwide organization helps customers in nearly 100 countries to optimize their processes. Alfa Laval has 42 major production units (22 in Europe, 10 in Asia, 8 in the US and 2 in Latin America).

The company has over 17,000 employees, the majority of whom are located in Sweden, Denmark, India, China, the US and France.

Manufactures and Sells Snuff, Snus, Cigarettes, Tobacco related products, Lighers, Matches etc and company has its headquarters in Sweden.

Leading Retail Company with a focus on food and health with headquarters in Sweden. Company also operates in real estate sector and pharmacy chain.

Metals company involved in exploration, extraction and processing metal products using Copper, Zinc, Lead, Silver and Gold. Company headquarters in Stockholm, Sweden.

Biopharmaceutical company with headquarters in Stockholm, Sweden. Sobi is an integrated biotechnology company with in-house capabilities that encompass the entire value chain, from research, to preclinical and clinical development, biologics manufacturing and supply, to patient access and distribution. This integrated approach is a prerequisite for providing proprietary drugs, and an enabler for partnerships, especially at early stages of drug development.